Dr Popat on OS Outcomes With Amivantamab Plus Chemotherapy in EGFR-Mutated, Advanced NSCLC
Darolutamide Plus ADT Improves rPFS in mHSPC
Abemaciclib/ET Combo Improves Responses vs Chemo in Aggressive HR+/HER2– Breast Cancer
Multivariate Analysis Provides Additional Insight on Efficacy of 177Lu-Dotatate in GEP-NETs
2 Commerce Drive
Cranbury, NJ 08512